Wang Ying-Jian, Bao Tao, Li Kun-Kun, Zhao Xiao-Long, Guo Wei
Department of Thoracic Surgery, Daping Hospital, Army Medical University, Chongqing, China.
Wideochir Inne Tech Maloinwazyjne. 2022 Jun;17(2):317-325. doi: 10.5114/wiitm.2022.114526. Epub 2022 Mar 16.
The prognostic value of high body mass index (BMI) in patients with esophageal squamous cell carcinoma (ESCC) is still controversial.
To evaluate the impact of high BMI on postoperative complications and survival after minimally invasion esophagectomy (MIE) for ESCC patients.
Three hundred and fourteen consecutive ESCC patients were used to analyze the potential association between high BMI and postoperative complications and survival.
Patients were divided into two groups. There was no significant difference between high and low BMI groups in terms of postoperative complications, including respiratory disease (p = 0.8362), pneumothorax (p = 0.6058), anastomotic leakage (p = 0.8678), chylothorax (p = 0.9062), cardiovascular disease (p = 0.5763), vocal cord paresis (p = 0.8349), wound infection (p = 0.5763) and perioperative death (p = 0.7179). Patients in the high BMI group had a longer operative time (p = 0.003) and more blood loss (p = 0.002) than in the low BMI group. There was no difference in number of retrieved lymph nodes between the two groups (p = 0.728). Patients could not benefit from high BMI in overall survival (OS) (p = 0.2459). High BMI was not an independent prognostic factor for survival (p = 0.1735, HR = 0.776 and 95% CI: 0.5386-1.1180).
High BMI is associated with prolonged operative time and increased blood loss in MIE. However, high BMI is not associated with postoperative complications and not an independent prognostic factor for survival in ESCC patients who undergo MIE.
高体重指数(BMI)对食管鳞状细胞癌(ESCC)患者的预后价值仍存在争议。
评估高BMI对ESCC患者行微创食管切除术(MIE)后术后并发症及生存的影响。
连续纳入314例ESCC患者,分析高BMI与术后并发症及生存之间的潜在关联。
患者分为两组。高BMI组与低BMI组在术后并发症方面无显著差异,包括呼吸系统疾病(p = 0.8362)、气胸(p = 0.6058)、吻合口漏(p = 0.8678)、乳糜胸(p = 0.9062)、心血管疾病(p = 0.5763)、声带麻痹(p = 0.8349)、伤口感染(p = 0.5763)及围手术期死亡(p = 0.7179)。高BMI组患者的手术时间比低BMI组更长(p = 0.003),失血量更多(p = 0.002)。两组之间的淋巴结清扫数目无差异(p = 0.728)。高BMI患者在总生存期(OS)方面无获益(p = 0.2459)。高BMI不是生存的独立预后因素(p = 0.1735,HR = 0.776,95% CI:0.5386 - 1.1180)。
高BMI与MIE手术时间延长及失血量增加相关。然而,高BMI与术后并发症无关,也不是接受MIE的ESCC患者生存的独立预后因素。